Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

昆莲 - NMPA Drug Approval Details

Approvals/NMPA/Breviscapine Tables

Approved

中药

Breviscapine Tables

云南白药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Jun 16, 2020
Approval ID: 7LeafeFRglN
Company: 云南白药集团股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeafeFRglN
Approval Number: 国药准字Z53020575
Generic Name: 灯盏花素片
Generic Name En: Breviscapine Tables
Brand Name: 昆莲
Drug Type: 中药
Dosage Form: 片剂
Strength: 每片含灯盏花素20mg
Reg Date: 2020-06-16
Company Name: 云南白药集团股份有限公司
Production Company Name: 云南白药集团股份有限公司
Production Company Address: 云南省昆明市呈贡新区云南白药集团股份有限公司
Company Detail Path: /organization/yunnan-baiyao-group-co-ltd
Production Company Detail Path: /organization/yunnan-baiyao-group-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 16, 2020

Approval ID

7LeafeFRglN

Type

中药

Back to NMPA Approvals